ReviewInternational journal of molecular sciences2023

Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML.

Elisa Meddi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.